Copyright
©2014 Baishideng Publishing Group Inc.
World J Stem Cells. Jul 26, 2014; 6(3): 355-366
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.355
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.355
Figure 1 Colony forming unit isolated from human peripheral blood mononuclear cells using commercial colony forming unit-hill assay.
Figure 2 Cobble-shaped outgrowth endothelial progenitor cells from human peripheral blood at day 14.
Figure 3 Cardiovascular-related pharmacological therapies which may affect numbers and function of endothelial progenitor cells.
TZDs: Thiazolidinedione; DPP4I: Dipeptidyl peptidase 4 inhibitors; ARBs: Angiotensin II receptor blockers; ACEI: Angiotensin converting enzyme inhibitors; CCBs: Calcium channel blockers.
- Citation: Lee PSS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells 2014; 6(3): 355-366
- URL: https://www.wjgnet.com/1948-0210/full/v6/i3/355.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v6.i3.355